Skip to content

Friday, July 26, 2024

Latest:

Reflections on medical advocacy
Congratulations, Dr. James R. Lupski, 2024 Mendel Lecturer and recipient of the Gilded Pea Award!
Benefits of low impact workouts: Pilates, dance and barre
Eating healthy on a budget: Tips and tricks from a registered dietitian
Defective serotonin 2C receptors lead to memory deficits in mice and humans

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

fresolimumab

Targeting TGF-β for treatment of osteogenesis imperfecta

March 22, 2022 brittle bone disease, fresolimumab, osteogenesis imperfecta, Research, TGF-β, treatment

A monoclonal antibody therapy that neutralizes TGF-β produced promising results in a Phase 1 clinical trial.

From the Labs: Image of the Month

From the Labs: The wooly mammoth emerges from the past.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951